Speaker illustration

Doctor Tomotaka Yoshiyama

Osaka City General Hospital, Osaka (Japan)

Utility of the plasma human atrial natriuretic peptide for predicting the left atrial reverse remodeling after the catheter ablation in patients with atrial fibrillation

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Atrial Fibrillation - Clinical and epidemiological aspects

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb